New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Orgenesis Inc.
ORGS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

21M

Biotechnology

Next Earning date - 11 Nov 2024

21M

Biotechnology

Next Earning date - 11 Nov 2024

4.37USD
Shape-0.05 ( -1.13%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-66%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

60%

Quote Panel

Shape
Updated October 3, 2024
1W -18.87 % 1M -35.82 % 3M -36.67 % 1Y -33.85 %

Key Metrics

Shape
  • Market Cap

    20.85M


  • Shares Outstanding

    4.77M


  • Share in Float

    4.23M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    4.37


  • Average Volume

    22580


  • Beta

    1.206


  • Range

    2.5-10.8


  • Industry

    Biotechnology


  • Website

    https://www.orgenesis.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

Nanx

P/S Ratio

-11.08x

P/B Ratio

-0.8

Debt/Equity

308.4%

Net Margin

$-8.0

EPS

How ORGS compares to sector?

P/E Ratio

Relative Strength

Shape

ORGS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$70M

Shape28477%

2024-Revenue

$6.10

Shape2752%

2024-EPS

$45M

Shape-1242%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.05
vs 0.42

Q4.22

arrow
arrow

N/A

-0.16
vs -0.20

Q1.23

arrow
arrow

N/A

-0.17
vs -0.16

Q2.23

arrow
arrow

N/A

-0.15
vs -0.22

Q3.23

arrow
arrow

N/A

-0.43
vs -0.05

Q4.23

arrow
arrow

N/A

-1.09
vs -0.16

Q1.24

arrow
arrow

N/A

-0.29
vs -0.17

Q2.24

arrow
arrow

N/A

-2.30
vs -0.15

Q3.24

arrow
arrow

+495%

1.7
vs -0.43

Q4.24

arrow
arrow

+330%

2.5
vs -1.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-8%

8M  vs 8.7M

Q4.22

arrow
arrow

+98%

13.6M  vs 6.9M

Q1.23

arrow
arrow

-2%

7M  vs 7.2M

Q2.23

arrow
arrow

-3%

7M  vs 7.2M

Q3.23

arrow
arrow

-99%

110K  vs 8M

Q4.23

arrow
arrow

-200%

-13599000.00  vs 13.6M

Q1.24

arrow
arrow

-98%

141K  vs 7M

Q2.24

arrow
arrow

-96%

246K  vs 7M

Q3.24

arrow
arrow

+16718%

18.5M  vs 110K

Q4.24

arrow
arrow

+278%

24.2M  vs -13599000

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.17

Q4.22

arrow
arrow

-5%

-0.05
vs -0.05

Q1.23

arrow
arrow

-15%

-0.15
vs -0.05

Q2.23

arrow
arrow

-17%

-0.17
vs -0.15

Q3.23

arrow
arrow

+102%

1.02
vs -0.17

Q4.23

arrow
arrow

+164%

1.64
vs 1.02

Q1.24

arrow
arrow

+35%

0.35
vs 1.64

Q2.24

arrow
arrow

+57%

0.57
vs 0.35

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

17

17
vs 18

-6%

Q4.22

arrow
arrow

21

21
vs 17

24%

Q1.23

arrow
arrow

20

20
vs 21

-5%

Q2.23

arrow
arrow

21

21
vs 20

5%

Q3.23

arrow
arrow

20

20
vs 21

-5%

Q4.23

arrow
arrow

20

20
vs 20

NA

Q1.24

arrow
arrow

16

16
vs 20

-20%

Q2.24

arrow
arrow

18

18
vs 16

13%

Earnings Growth

Latest News

ORGS

globenewswire.com

17 hours ago